GRIMES & Co WEALTH MANAGEMENT, LLC

Position in VRTX — Vertex Pharmaceuticals Inc / Ma

CIK 1321993 WESTBOROUGH, MA

Position in VRTX

as of Jun 30, 2026 · filed Jul 17, 2026 Compact

Position Value

$377,017

+$87,660 QoQ

Shares Held

759

+17.1% QoQ

Ownership

0.000%

of shares outstanding

% of Portfolio

0.02%

of 13F equity value

Holder Rank

#1,159

of 1,735 holders

Holding Since

Mar 2022

12 quarters on record

Voting authority Sole 100% Shared 0% None 0%

Healthcare · as of Jun 30, 2026

GRIMES & Co WEALTH MANAGEMENT, LLC holds $18,023,555 across 11 Biotechnology names. VRTX ranks #4 (2.1% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	INCY	Incyte Corp	134,448	$15,241,025
2	IBRX	ImmunityBio, Inc.	53,307	$466,702
3	RVMD	Revolution Medicines, Inc.	2,369	$443,665
4	VRTX	Vertex Pharmaceuticals Inc / Ma This page	759	$377,017
5	TGTX	Tg Therapeutics, Inc.	6,100	$335,134
6	ARWR	Arrowhead Pharmaceuticals, Inc.	4,011	$326,936
7	AXSM	Axsome Therapeutics, Inc.	1,287	$315,018
8	INVA	Innoviva, Inc.	9,722	$220,786

12 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-06-30	$377,017	759	+17.1%	Shares	Sole	2026-07-17
2026-03-31	$289,357	648	+1.9%	Shares	Sole	2026-04-21
2025-12-31	$288,336	636	+2.4%	Shares	Sole	2026-02-03
2025-09-30	$243,208	621	-12.3%	Shares	Sole	2025-10-27
2025-06-30	$315,201	708	+0.3%	Shares	Sole	2025-07-22
2025-03-31	$342,282	706	+8.8%	Shares	Sole	2025-04-17
2024-12-31	$261,352	649	+3.0%	Shares	Sole	2025-01-21
2024-09-30	$293,000	630	+0.2%	Shares	Sole	2024-10-22
2024-06-30	$294,824	629	+3.6%	Shares	Sole	2024-07-22
2024-03-31	$253,732	607	+19.3%	Shares	Sole	2024-04-17
2023-12-31	$207,107	509	-44.1%	Shares	Sole	2024-01-24
2022-03-31	$237,743	911	—	Shares	Sole	2022-05-06
No filing history on record for this holder in this stock.